Accelerate Diagnostics News

Express News | Accelerate Diagnostics - Received Written Notice From Nasdaq Notifying Co That It Had Regained Compliance With Minimum Bid Price Requirement

ReutersJun 5 17:18 ET

Accelerate Diagnostics Unveils Executive Incentive Plan Linked to FDA Goals

TipRanksMay 30 17:20 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersOneMedNet (NASDAQ:ONMD) stock moved upwards by 15.6% to $1.7 during Thursday's after-market session. The company's market cap stands at $40.5 million. 23andMe Holding (NASDAQ:ME) shares increas

BenzingaMay 23 16:31 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday's regular session. The market value of their outstanding shares is at $10.2 million. Genelux (NASDAQ:GNLX)

BenzingaMay 21 12:31 ET

Accelerate Diagnostics' Shareholder Decisions at Annual Meeting

TipRanksMay 13 16:23 ET

Accelerate Diagnostics | 10-Q: Quarterly report

SEC announcementMay 13 13:04 ET · Announcements

Express News | Corrected-(Official)-Accelerate Diagnostics Inc: Qtrly Shr Loss $0.74 (Not '$0.88')(May 8)

ReutersMay 10 17:47 ET

Express News | RPT-Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

ReutersMay 10 17:47 ET

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 12:28 ET

Q1 2024 Accelerate Diagnostics Inc Earnings Call

Yahoo FinanceMay 9 06:04 ET

Accelerate Diagnostics Inc (AXDX) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 9 03:43 ET

Accelerate Diagnostics, Inc. (AXDX) Q1 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (AXDX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 8 19:50 ET

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Yahoo FinanceMay 8 18:25 ET

Express News | Accelerate Diagnostics Inc: Qtrly Shr Loss $0.88

ReutersMay 8 17:37 ET

Accelerate Diagnostics Q1 2024 GAAP EPS $(0.88) Misses $(0.72) Estimate, Sales $2.921M Miss $3.000M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.72) by 22.22 percent. This is a 48.54 percent increase over losse

BenzingaMay 8 17:16 ET

Accelerate Diagnostics 1Q R&D Expenses $5.2M >AXDX

Accelerate Diagnostics 1Q R&D Expenses $5.2M >AXDX

Dow JonesMay 8 16:46 ET

Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, Vs. Street Est of $3M

04:45 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M

MT NewswiresMay 8 16:45 ET

Express News | Accelerate Diagnostics Q1 Sales USD 2.9 Million

ReutersMay 8 16:42 ET

Express News | Accelerate Diagnostics Q1 Net Income USD -17 Million

ReutersMay 8 16:42 ET

Express News | Accelerate Diagnostics Q1 Gross Margin 25%

ReutersMay 8 16:42 ET